prednisolone has been researched along with Dyslipidemias in 3 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.
| Excerpt | Relevance | Reference |
|---|---|---|
| " History of lupus nephritis and a higher average dose of prednisolone used since diagnosis were associated with cIMT progression in patients." | 3.96 | Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisol ( Ajeganova, S; Frostegård, J; Gustafsson, T; Hafström, I; Lindberg, L, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ajeganova, S | 1 |
| Gustafsson, T | 1 |
| Lindberg, L | 1 |
| Hafström, I | 1 |
| Frostegård, J | 1 |
| Saito, M | 2 |
| Yajima, N | 1 |
| Yanai, R | 1 |
| Tsubokura, Y | 1 |
| Ichinose, K | 1 |
| Yoshimi, R | 1 |
| Ohno, S | 1 |
| Sada, KE | 1 |
| Numakura, K | 1 |
| Kagaya, H | 1 |
| Yamamoto, R | 1 |
| Komine, N | 1 |
| Hiroshi, T | 1 |
| Akihama, S | 1 |
| Inoue, T | 1 |
| Narita, S | 1 |
| Tsuchiya, N | 1 |
| Habuchi, T | 1 |
| Niioka, T | 1 |
| Miura, M | 1 |
| Satoh, S | 1 |
3 other studies available for prednisolone and Dyslipidemias
| Article | Year |
|---|---|
Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisol
Topics: Adult; Aged; Cardiovascular Diseases; Carotid Artery Diseases; Carotid Intima-Media Thickness; Case- | 2020 |
Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study.
Topics: Adult; Atherosclerosis; Cohort Studies; Cross-Sectional Studies; Dyslipidemias; Female; Glucocortico | 2021 |
Characterization of clinical and genetic risk factors associated with dyslipidemia after kidney transplantation.
Topics: Adult; Aged; Case-Control Studies; Dyslipidemias; Female; Humans; Immunosuppressive Agents; Kidney T | 2015 |